Top Markets
#1 Derive Derive +32.58%
#2 Cross Cross +15.28%
#3 The Bitcoin Bull The Bitcoin Bull +10.40%
#4 Audiera Audiera +10.09%
#5 Biconomy Biconomy +9.51%
#6 Gama Token Gama Token +9.19%
#7 Geodnet Geodnet +8.43%
#8 Velvet Velvet +8.23%
#9 Based Based +7.18%
#10 Starpower Starpower +6.79%
Coin of the day
Derive Derive
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Classifica tra le azioni #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Prezzo delle azioni
$0.05207079
Ultima sincronizzazione: 2023-11-15
Capitalizzazione di mercato
$3.38M
Variazione (1 giorno)
0.13%
Variazione (1 anno)
0.00%
Paese
AU
Scambia Kazia Therapeutics Limited (KZA)

Categoria

Healthcare
EPS per Kazia Therapeutics Limited (KZA)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Kazia Therapeutics Limited, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Kazia Therapeutics Limited da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE